General Information of This Metabolic Reaction (MR) (ID:
MR004884) |
Formula |
Reactant |
Nateglinide |
Product |
2-{[4-(2-hydroxypropan-2-yl)cyclohexyl]formamido}-3-phenylpropanoic acid |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Cytochrome P450 2C9 (CYP2C9)
|
DME Info
|
Cytochrome P450 3A4 (CYP3A4)
|
DME Info
|
Metabolic Type
|
Oxidation
-
Aliphatic hydroxylation
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
References |
1 |
Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675.
|
2 |
Pharmacokinetics of nateglinide enantiomers and their metabolites in Goto-Kakizaki rats, a model for type 2 diabetes mellitus
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.